Safety of HY209 in healthy volunteers
Part of Brain & nervous system, Mental health clinical trials.
This study tests the safety and tolerability of a new medication called HY209 in healthy volunteers. It helps researchers understand how the drug affects the body and if it causes any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy male between 19 and 45 years old.
- Your weight is between 55 and 90 kg (121–198 lbs) and your BMI is between 18 and 30.
- You have no major health problems like heart disease, liver issues, or diabetes.
- You do not smoke or have quit smoking at least 6 months ago.
- You are not taking any prescription or over-the-counter medications, including vitamins or supplements.
- You agree to avoid alcohol and certain foods (like grapefruit) during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.
This study tests a new oral medication, HY8931, in healthy adults to see if it is safe and how the body processes it. You will be closely monitored during the trial.
This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.
This trial tests a new drug called HY6725 in healthy volunteers to see if it is safe and how the body processes it. It may help pave the way for future treatments.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
Hear when a new Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.